Keravision Inc/DE – ‘8-K’ for 7/1/99

On:  Thursday, 7/1/99   ·   For:  7/1/99   ·   Accession #:  946154-99-20   ·   File #:  0-26316

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         3      9K 
 2: EX-99.23    News Release Dated 6/21/1999                           3±    12K 
 3: EX-99.24    News Release Dated 6/26/1999                           2±    11K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 3
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
                                                       Total Number of Pages:  3
                                                                              --

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549 

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: July 1, 1999    

Commission File Number:  0-26208

================================================================================

KERAVISION, INC.

(Exact name of Registrant as specified in its Charter)

DELAWARE                                               77-0328942     
(State of Incorporation)                                 (I.R.S. Employer       
                                                   Identification No.)

48630 MILMONT DRIVE 
FREMONT, CA  94538
(Address of principal executive offices)

(510) 353-3000
(Registrant's telephone number) 

8-K
2nd Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 2nd
ITEM 5.  OTHER EVENTS                                                           

On June 21, 1999, KeraVision, Inc. announced Intacs for Myopia Now Offered
By 187 Vision Correction Surgeons In U.S. Further details regarding this        
announcement are contained in the Company's new release dated June 21, 1999     
attached as exhibit  hereto and incorporated reference herein.                  

On June 26, 1999, KeraVision, Inc. announced Intacs Prove Effective As    
Treatment For Nearsightedness For First Group Of Canadian Patients. Further     
details regarding this announcement are contained in the Company's new release  
dated June 26, 1999 attached as exhibit  hereto and incorporated reference      
herein.                                                                         

ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS     

(a)   Exhibits:                                               

           99.23 KeraVision, Inc. News Release dated June 21, 1999

           99.24 KeraVision, Inc. News Release dated June 26, 1999

2 

8-K
Last Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 3rd
SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the    
undersigned thereunto duly authorized.                                          

        KERAVISION, INC.

               /s/Mark Fischer-Colbrie
               -----------------------
            Mark Fischer-Colbrie
                   Vice President, Finance and
                          Administration and Chief Financial
                       Officer(Principal Financial and
           Accounting Officer)

Date: July 1, 1999                                                              

3 

Dates Referenced Herein

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on / For Period End:		7/1/99		1		3			None on these Dates
		6/26/99		2
		6/21/99		2
									List all Filings